Abstract
Background
Four distinguishing histopathological characteristics of thoracic aortic aneurysms and dissections (TAADs) are the fragmentation or degradation of elastic fibers, loss of smooth muscle, pooling of glycosaminoglycans, and remodeling of fibrillar collagens. Of these, pooling of glycosaminoglycans appears to be unique to these lesions.
Methods
This review acknowledges the importance of dysregulated transforming growth factor–beta (TGF-β) in TAADs and offers a complementary hypothesis that increased TGF-β could contribute to the accumulation of glycosaminoglycans in the media of the proximal thoracic aorta. Regardless, observed pools of glycosaminoglycans could decrease tensile strength, cause stress concentrations, and increase intralamellar swelling pressure, all of which could initiate local delaminations that could subsequently propagate as dissections and result in a false lumen or rupture.
Conclusions
There is a pressing need to investigate potential mechanical as well as biological consequences of accumulated glycosaminoglycans in TAADs and to elucidate responsible signaling pathways, with particular attention to synthetic cells of non-mesodermal lineage. Such research could provide insight into the mechanisms of dissection and the seemingly paradoxical role of the over-expression of a cytokine that is typically associated with fibrosis but is implicated in a degenerative disease of the aorta that can result in a catastrophic mechanical failure.
Keywords: transforming growth factor–beta, thoracic aneurysm, GAG, proteoglycan, stress concentration, wall strength
Introduction
Aneurysms arise preferentially in three regions of the human vasculature, the thoracic aorta, intracranial circulation, and infrarenal abdominal aorta. Despite differences in etiology, these three classes of aneurysms share three distinguishing structural characteristics: proteolytic degradation of or mechanical damage to elastic fibers, loss of functional smooth muscle cells, and remodeling of fibrillar collagens [1–3]. Of particular note, however, neither intracranial nor abdominal aortic aneurysms typically exhibit localized accumulations of glycosaminoglycans/proteoglycans (GAGs/PGs) and these two classes of aneurysms typically do not dissect. In stark contrast, it has long been known that a unique histopathological characteristic of thoracic aortic aneurysms and dissections (TAADs) is the accumulation of significant pools of GAGs/PGs within the media in regions of compromised elastic fibers and smooth muscle cells [4,5]. Indeed, this unique feature continues to be recognized as singularly characteristic of TAADs–see, for example, Figure 1, which is reprinted from [6]. See, too, Figure 2 in [7], Figure 3 in [8], Figure 2 in [9], Figures 1–3 in [10], Figure 1 in [11], Figure 2 in [12], Figure 1 in [13], and Figure 2 in [14]. It should be noted that these different histological images come from patients representing a wide range of ages, from children to young and old adults, and presenting with diverse disease origins, including bicuspid aortic valve, Marfan syndrome, familial TAAD, Loeys-Dietz syndrome, and idiopathic TAADs. Nevertheless, there has not been any prior study of possible biomechanical consequences of pooled GAGs/PGs in TAADs even though it is ultimately the mechanics that dictates the fate, that is, possible dissection or rupture, of the compromised aortic wall. Similarly, there has not been any discussion of possible roles of dyregulated transforming growth factor–beta (TGF-β), a recognized key player in many cases of TAADs [12,15,16], in contributing to the local accumulation of GAGs/PGs [7]. The purposes of this review, therefore, are to synthesize a diverse literature that is seldom considered together and to offer a new hypothesis for testing, namely, that alterations in the intramural mechanical stress field arising from localized accumulations of GAGs/PGs could help initiate aortic dissections and that dyregulated TGF-β signaling could contribute to this perturbation in wall homeostasis.
Figure 1.

Sections of the medial layer of the human ascending aorta stained with Alcian blue (which stains GAGs blue) for both a normal (B) and aneurysmal (F) wall. In particular, note the marked pooling of GAGs in the latter, indicated by the black star, and the lack of smooth muscle or elastic fibers within these pools of GAGs. In contrast, the black arrow points to a normal structure in (B), consisting primarily of smooth muscle, collagen, and modest distributed GAGs. Reprinted from [6], with permission from Elsevier (license number 2911570557067).
Aortic Wall Structure
The normal thoracic aorta consists of three well-defined layers: intima, media, and adventitia. Briefly, the intima consists of a monolayer of endothelial cells that adhere to a basement membrane, which in turn consists primarily of type IV collagen and laminin. Albeit extremely important in arterial homeostasis and hemostasis, the intima only occupies about 5% of the normal thoracic aorta [17] and it is generally considered to confer little overall load bearing capability. The media consists of ~70 layers of alternating elastic laminae and embedded smooth muscle cells, adhesion molecules, collagen fibers (primarily types I, III, and V), and GAGs/PGs [18]; these separate layers are the building blocks of the media and have been referred to as medial lamellar units (Figure 2). Serving as the parenchymal layer of the aorta, the media occupies nearly 80% of the wall and contributes substantially to overall load bearing, particularly under physiologic hemodynamic conditions. The adventitia consists primarily of type I collagen, but also admixed elastic fibers and fibroblasts [19]; it occupies about 15% of the wall [17]. The adventitia is thought by some to serve, in part, as a strong sheath that mechanically protects the smooth muscle cells of the media from overstretching during acute conditions of extreme loading [20]. Historically, and for good reason, elastic fibers, contractile smooth muscle, and fibrillar collagens have long been considered to be the most important contributors to the structural integrity of the normal aortic wall, particularly given that the two primary mechanical stresses in the wall – circumferential and axial – remain tensile throughout the cardiac cycle [21]. Quantifying the associated mechanics is widely recognized as important both for understanding the artery as a structure [21] and because all three cell types of the normal aortic wall (endothelial, smooth muscle, and fibroblasts) are mechanobiologically responsive to even small changes in mechanical stimuli [22].
Figure 2.
Schematic drawing of a normal aortic medial lamellar unit (cf. [18]) consisting of paired elastic laminae (at the top and bottom) with an embedded smooth muscle cell (SMC) as well as collagen fibers, adhesion molecules (e.g., fibronectin), and GAGs (not to scale). Shown, too, are thin “radially oriented” elastic fibers (i.e., elastin and associated microfibrils, predominately fibrillin-1) that may provide direct mechanical connections between the elastic laminae and smooth muscle cell and thus a mechanosensory capability beyond the typical cytoskeletal (CSK) – integrin –extracellular matrix (fibronectin/collagen) axis. It is possible that negatively charged GAGs sequester water and may thereby contribute a normal intralamellar pressure that could help maintain the thin elastic fibers in tension. The primary directions of tension are, however, the circumferential and axial directions, with normal lamellar tensions on the order of 2 N/m. Artwork by Carolyn Valentin.
Elastic fibers consist primarily of elastin, but also microfibrils that include the fibulins, fibrillins, Emilin-1, and microfibril associated glycoproteins [23]. It is thought, for example, that the fibulins and fibrillins contribute to elastogenesis and the long-term stability of elastic fibers. Indeed, in contrast to collagen fibers, which turnover continuously within the arterial wall [24], elastic fibers appear to be deposited primarily during the perinatal period and, because of their normally long half-life, they must withstand the millions of cycles of loading throughout one’s lifetime [25]. Proteolytic degradation of, or mechanical damage to, elastic fibers thus results in irreversible effects on wall structure, biology, and mechanical properties and, as noted above, clearly plays a role in all three major classes of aneurysms (thoracic aortic, intracranial, and abdominal aortic).
Aortic dissections tend to propagate much easier within elastic lamellae than across the lamellae [26,27], which is consistent with clinical observations of extensive dissections prior to rupture (e.g., [28]). An unresolved question, however, is: What initiates the initial defect, or delamination, that renders the wall vulnerable to subsequent dissection and possible rupture? That is, whereas it is often tacitly assumed that dissections, and the associated false lumens, arise following an intimal tear that propagates into the media under the action of blood pressure (cf. [29,30]), it has been noted correctly that it is actually “uncertain whether the initiating event is a primary rupture of the intima with secondary dissection of the media” [31]. As discussed below, it is suggested herein that pools of GAGs/PGs may represent initiation sites within the media that contribute to the development and propagation of a dissection that could subsequently lead to an intimal tear or rupture.
Fundamental Role of Genetics
Dissections of the thoracic aorta occur most often in the ascending portion (Stanford Type A), but in the descending portion as well (Stanford Type B). Although these dissections can result from blunt trauma or extreme physical exertion [12], they frequently associate with heritable disorders and aneurysmal dilatations [3,9,12,16]. In particular, syndromic TAADs include those resulting from mutations in genes coding fibrillin-1 (Marfan syndrome), transforming growth factor beta receptor II (Loeys-Dietz syndrome), and collagen III (Ehlers-Danlos IV syndrome) – see, for example, [11]. Similarly, mutations in genes coding for alpha smooth muscle actin and smooth muscle specific beta myosin are responsible for a significant percentage of familial TAADs [9].
With regard to Marfan syndrome, loss of the structural role of fibrillin-1 in stabilizing elastic fibers, which would be expected to hasten mechanical fatigue and thus the fragmentation or degradation of these fibers, must contribute to the compromised structural integrity of the aortic wall [32,33] and subsequent mechanobiological responses [9,34]. Nevertheless, another important finding was that normal fibrillin-1 also contributes to the sequestration of latent TGF-β within the extracellular matrix, which attenuates the activity of this important cytokine [35,36]. Hence, loss of fibrillin-1 can increase TGF-β activity and thereby play another important role in the natural history of TAADs in Marfan syndrome [15,16,37]. Similarly, albeit seemingly paradoxical, mutations in the gene that codes for transforming growth factor – beta receptor II also lead to increased TGF-β activity and play an important role in Loeys-Dietz syndrome [15,16]. Amongst other effects, altered transforming growth factor beta receptor II decreases contractile protein expression in thoracic aortic smooth muscle cells, which has been suggested to play a role in decreased fibronectin/fibrillin-1 assembly within the extracellular matrix and thus decreased sequestration of latent TGF-β [38]. Indeed, altered alpha smooth muscle actin and beta myosin, which similarly compromise smooth muscle contractility, have also been shown to increase TGF-β activity [39]. It is thus clear that, despite very different reasons, an increased bioavailability of TGF-β is involved in diverse types of TAADs, which in many cases likely exacerbates the diminished structural integrity of the wall that results directly from mutations in the genes that code important structural proteins (e.g., collagen III, actin, or myosin) and glycoproteins (e.g., fibrillin-1, which co-localizes with elastin to form elastic fibers).
Transforming Growth Factor – beta
TGF-β is pleiotropic cytokine that belongs to a superfamily of extracellular polypeptides that regulate diverse cellular activities, including adhesion, migration, division, differentiation, and the production of diverse extracellular matrix constituents [40,41]. Notwithstanding its important roles in normal arterial development and homeostasis, TGF-β is perhaps best known as a pro-fibrotic cytokine. In particular, TGF-β can stimulate vascular smooth muscle cells and fibroblasts to increase their synthesis of collagen (a hallmark of TAADs; [42]), downregulate the activity of matrix metalloproteinases (MMPs, which play important roles in TAADs; [43]), upregulate the activity of tissue inhibitors of MMPS (TIMPs), and upregulate the activity of plasminogen activator inhibitor – 1 (PAI-1), all of which should contribute to a pro-fibrotic phenotype [40,41]. Indeed, over-expression of TGF-β can stabilize pre-existing abdominal aortic aneurysms [44] and similarly prevent aortic dilatation and atherosclerotic plaque rupture in apolipoprotein null mice [45], each consistent with the notion that increased collagen synthesis, decreased MMP activity, and increased TIMP activity should strengthen the wall of a lesion. Also consistent with these findings, it was recently shown that increased TGF-β activity can stimulate adventitial fibroblasts to downregulate miR-29b (a microRNA that regulates genes that mediate the turnover of extracellular matrix), which in turn led to an increased deposition of collagen; when miR-29b was inhibited further, there was a marked attenuation of abdominal aortic aneurysm development [46,47]. For obvious reasons, then, the precise roles of increased TGF-β activity in syndromic and familial TAADs remain perplexing. In other words: How does a cytokine best known for its pro-fibrotic activity contribute significantly to degenerative thoracic aortic diseases characterized by aneurysmal dilatation or dissection?
Possible reasons for the unexpected deleterious consequence of increased TGF-β activity in TAADs include the existence of both canonical (via Smad2/3; [48]) and non-canonical (via MAPK; [49]) TGF-β signaling pathways. Non-canonical signaling has been suggested, for example, to increase MMP activity [50], which could compromise the aortic wall. Another suggested reason is that TGF-β activity could exert differential effects on different cell types and arteries. For example, the aforementioned miR-29b study shows differential activity by smooth muscle cells and fibroblasts in mouse models of abdominal aortic aneurysms [46]. Moreover, smooth muscle cells and fibroblasts in the proximal thoracic and infrarenal abdominal aorta have different embryonic lineages [16,51,52], and it has long been known that TGF-β differentially stimulates cells from the neural crest (proximal thoracic) and mesoderm (abdominal) – see, for example, [53] and [54]. There is clearly a need to determine whether this regional heterogeneity could explain, at least in part, a possibly protective role of TGF-β in abdominal aortic aneurysms [44] and a detrimental role in TAADs, at least during particular periods of lesion development (e.g., [55]). In summary, however, as recognized by many and noted in a recent Nature review, we must conclude at present that “Little is known about the precise pathogenetic sequence downstream of TGF-β that is involved in aneurysm progression” [16].
Glycosaminoglycans/Proteoglycans
According to Alberts et al. [56], glycosaminoglycans (GAGs) consist of linear chains of repeating disaccharide units; they are highly negatively charged and thus sequester water and contribute directly to the compressive, rather than tensile, stiffness of a soft tissue. The four primary classes of GAGs are hyaluronan, chondroitin sulfate/dermatan sulfate, heparan sulfate, and keratan sulfate. Of these, chondroitin sulfate, dermatan sulfate, and hyaluranon are commonly found in the aortic wall [57]. Hyaluronan is unique in that it does not associate directly with a protein core. It expands significantly when hydrated and occupies large volumes of the extracellular space, thus allowing it both to resist compressive loads and to facilitate cell migration; it is particularly abundant in morphogenesis and early wound healing. When GAGs associate with a protein core, the composite molecules are called proteoglycans (PGs). In addition to serving as space-filling, negatively charged gels within the extracellular matrix, PGs also control the activity of many cytokines, chemokines, and proteases. The primary PGs in arteries are versican, which is rich in chondroitin sulfate, and the small leucine-rich PGs biglycan and decorin, which are rich in dermatan sulfate or chondroitin sulfate [18,57]. Under normal conditions, at least in heart valves, biglycan and decorin tend to exist in regions of cyclic tension whereas hyaluronan and versican tend to aggregate in regions of cyclic compression [58]. The former is consistent with biglycan and decorin contributing to collagen fibrillogenesis [59] and the latter is consistent with the ability of versican to bind hyaluronan and form large multi-molecular hydrophilic complexes within the aortic wall that support compressive loads [57]. It is interesting that decorin, like fibrillin-1, can also sequester TGF-β in the extracellular matrix.
GAGs/PGs are fundamental contributors to the development and maintenance of the structure and function of the aortic wall [18,57,60,61], hence it is unfortunate that their contributions to wall mechanics have not received the extensive consideration given to other structural constituents, namely, the elastic fibers, smooth muscle, and fibrillar collagens. Reasons for this prior lack of attention likely include the normally low mass fraction of GAGs/PGs (they occupy only ~ 1 to 5% of the normal arterial wall) and that they are thought to be most important mechanically in resisting compressive stresses. As noted earlier, the two primary stresses in the arterial wall are the circumferential and axial components, both of which are tensile and on the order of 100 kPa in magnitude in vivo; in contrast, the radial stress is compressive and on the order of only −10 kPa [21]. Nevertheless, recent studies using mutant mice reveal that, albeit indirectly, PGs can contribute significantly to the tensile strength of arteries. For example, recalling that biglycan aids in collagen fibrillogenesis, biglycan deficiency has been shown to lead to aortic rupture [62]. This study reminds us that whereas locally compromised elastic fibers or diminished smooth muscle contractility can allow an initial dilatation of the arterial wall [33,63], collagen fibers must ultimately be compromised for the wall to rupture [63,64].
Many studies report increased accumulations of GAGs/PGs in diverse vascular diseases and injuries, including atherosclerosis, hypertension, and diabetes (cf. [65–68]). Of particular note herein, accumulation of GAGs in mucopolysaccharidosis has been associated with aortic aneurysms [69,70]. There have also been reports of significant increases in hyaluronan and dermatan sulfate GAGs in dissecting aortas [5] and significant increases in versican in ascending aortic aneurysms, with no significant increases in biglycan [71]. Further reports that MMP-3 and particularly MMP-7 co-localize with accumulated GAGs/PGs in TAADs suggest that some of the mucoid material could be fragmented [6]. MMP-3, and -7 can also degrade elastin and collagen III [72,73], which could contribute further to medial degeneration. Of more importance herein, however, many reports also reveal that increased TGF-β activity leads to an increased production of GAGs/PGs within the arterial wall [57,66–68,74,75], similar to that in other tissues (e.g., [76–78]). In particular, Nataatmadja et al. [7] reported a significant increase in hyaluronan in aortic aneurysms in Marfan syndrome and specifically implicated the decreased fibrillin-1 and increased TGF-β as causative. This finding is supported by an earlier observation that cultured fibroblasts from Marfan patients exhibit significant increases in both hyaluronan (11-fold) and chondroitin sulfate (3-fold) production [79]. It should also be noted that angiotensin II has long been known to promote TGF-β activity [80], and angiotensin II and TGF-β have overlapping signaling pathways (e.g., Smad and MAPK; [41]). Indeed, there are reports that angiotensin II promotes the accumulation of PGs in atherosclerotic lesions [81] and that an angiotensin II type 1 receptor antagonist inhibits the accumulation of PGs in atherosclerosis [82]. These observations are particularly relevant here given that it was the effectiveness of the angiotensin II type 1 receptor antagonist losartan in preventing thoracic aneurysms in mouse models of Marfan syndrome that helped identify important roles of dysregulated TGF-β activity in TAADs [83].
Finally, it is interesting that there are reports of decreased GAGs/PGs in abdominal aortic aneurysms [84–86], which tend not to dissect. Again, this is in stark contrast to the aforementioned significant increase, indeed pooling, of GAGs/PGs in TAADs [6–14], which often dissect. This comparison again points to a possible difference in response between synthetic cells of non-mesodermal and mesodermal origin [16,51,52]. Also possibly related to this differential response, it was reported many years ago that, in chickens, the normal fixed charge density (resulting from the negatively charged GAGs/PGs) is 25% greater in the thoracic than the abdominal aorta [87], thus suggesting that GAG/PG production may vary regionally even under normal conditions. It should be noted further that, regardless of arterial segment, most of GAGs/PGs appear to reside primarily in the media in a healthy artery [88], which is also where most dissections tend to originate.
Possible Mechanical Effects of Pooled GAGs/PGs
Whereas little is known about mechanical roles of GAGs/PGs in arteries (cf. [88]), much has been learned regarding their importance in GAG-rich tissues such as cartilage. For example, it was recently suggested that central fissures could develop within tissue engineered cartilage due to the high Donnan swelling pressures that resulted from the negatively charged GAGs [89]. Briefly, based on physico-chemical principles [90], the so-called Donnan effect explains thermodynamically how equilibrium can be maintained while gradients or jumps exist in mobile ions (e.g., Na+ in an aqueous solution) due to a region of the system containing fixed molecules that are charged (e.g., negative charges due to SO3− or COO− groups within GAGs). These ionic gradients or jumps, in turn, alter the regional distribution of interstitial water and, as in the case of GAGs, cause a swelling pressure within the region containing the fixed charges. Indeed, it was shown many years ago that the high concentrations of GAGs in cartilage can cause significant interstitial Donnan swelling pressures, with values ranging from 16 kPa for a fixed charge density of 0.05 mEq per gram of wet tissue to 170 kPa for a fixed charge density of 0.18 mEq per gram [91]. This range of swelling pressures was confirmed more recently for solutions of chondroitin sulfate having fixed charge densities up to 0.35 mEq/ml [92], noting that tissue mass density is typically ~1.05 g/ml. Recall that chondroitin sulfate is similarly important in aortic mechanics (with a fixed charge density in the normal thoracic aorta on the order of 0.05 mEq/ml; [87,88]), particularly given the reported 2.6-fold increase in the chondroitin sulfate rich proteoglycan versican in human thoracic aortic aneurysms [71].
Given that the blood pressure induced compressive radial stress within the normal aortic wall is on the order of −10 to −16 kPa (where 10 kPa = 75 mmHg), we submit that pooled GAGs/PGs could produce intralamellar Donnan swelling pressures having magnitudes comparable to or well greater than normal compressive stresses. Such swelling (cf. [93]) could contribute to separating the elastic lamellae (Figure 3), as reported for both experimental models of thoracic aneurysms that dissect [94] and human data; for example, greater separation distances have been reported between elastic lamellae that contain accumulated GAGs/PGs [14], and dissections have been associated with marked pooling of GAGs/PGs [95]. Clearly, therefore, there is a need to examine rigorously if GAG-associated Donnan swelling pressures could directly cause delaminations within the aortic media that, in turn, could initiate dissections. Moreover, perhaps both prior to and after local dissection, swelling-induced disruptions of smooth muscle interactions with “radially” oriented elastic fibers (cf. Figure 3) could negatively impact cell mechanotransduction [96], perhaps leading to altered cell signaling pathways with deleterious effects on matrix turnover and thus wall homeostasis [97]. Similar concerns have been raised regarding perturbed mechanotransduction in cases of dyregulated smooth muscle contractility [9]. In addition, generation of elastin fragments or “elastin degradation products” due to swelling induced damage to inter-lamellar elastic fibers could also alter wall homeostasis [98] and thereby exacerbate the loss of structural integrity of the wall.
Figure 3.
Similar to Figure 2, but this schematic drawing depicts the central hypothesis herein. A localized accumulation of GAGs, on the right side of the medial lamellar unit, results in an increased Donnan swelling pressure, which in turn helps to separate the elastic laminae and possibly disrupt connections between the SMCs and either thin elastic fibers or the collagenous matrix. Such effects could initiate a local delamination and/or altered mechanosensitive cellular response leading to dysregulated wall homeostasis. Artwork by Carolyn Valentin.
With the exception of PGs that promote collagen fibrillogenesis, such as biglycan, GAGs contribute primarily to the compressive, not tensile, stiffness of a soft tissue. It is intuitive, therefore, that replacing tensile-bearing elastic fibers, contractile smooth muscle, and collagen fibers with pools of GAGs/PGs (cf. Figure 1), particularly hyaluronan and versican, within localized regions of the media would also necessarily reduce the tensile carrying capability of that portion of the wall. That is, one should expect a local weakening of the wall in response to the dominant cyclic circumferential and axial stresses within regions containing pools of GAGs/PGs. Moreover, it is well known in engineering that material or geometric discontinuities can give rise to “stress concentrations”, which for holes or cavities can typically raise the local stress by 2- to 3-fold. Possibly exacerbating this increase in stress is the often increased aortic pulse pressure [99] that results from stiffening of the aorta and the earlier return of reflected pressure waves in cases wherein elastic fibers are fragmented and collagen fibers remodeled, as, for example, in Marfan syndrome [33,100]. Recalling that MMP activity may also be heightened within the pools of GAGs/PGs [6], or the compromised aortic wall in general [50], the combination of local decreases in wall strength and increases in wall stress could further increase the likelihood of dissection or rupture (cf. [101]).
In summary then, pooling of GAGs/PGs within the aortic wall could contribute to the delamination of elastic lamellae via one of three means: Donnan swelling pressures, loss of tensile stiffness, and development of stress concentrations. Clearly, however, such concerns need to be investigated via rigorous calculations of the wall mechanics, which should account for the complex hemodynamic loads that act on the aortic wall and the nonlinear, regionally anisotropic, materially nonuniform properties of the residually stressed wall under cyclic finite deformations (cf. [21,102]). In contrast, recent finite element models of TAADs have inappropriately been based on isotropic linearized elasticity under the assumption of uniform homogenized wall properties [103–105], which cannot account for the characteristic histopathological features that are unique to TAADs.
Finally, given the apparently different degrees of structural defects amongst the different types of TAADs – for example, Maleszewski et al. [10] reported that Marfan syndrome is characterized by larger cystic spaces (220–500 × 200–1000 microns) and inter-lamellar fragmentation whereas Loeys-Dietz syndrome is characterized by smaller cystic spaces (20–50 × 100–200 microns) and intra-lamellar fragmentation – there is a need for disease-specific, microstructurally-motivated, biomechanical analyses. For example, notwithstanding structural implications associated with the accumulation of GAGs/PGs within the media in TAADs, Guo et al. [14] reported a novel genetic locus that appears to result in slowly expanding ascending aortic aneurysms having a low risk of dissection. The associated histopathology revealed a “focal loss of SMCs and increased proteoglycan deposition but only minimal degradation of the elastic fibers” which resulted in a “widening between elastic fibers.” These findings, like those from the biglycan null mouse [62], remind us of the multi-factorial biological nature of TAADs and associated structural consequences, and thus the need to consider mechanical consequences of varying the degrees of all four characteristic histopathologic features – fragmentation of elastic fibers, loss of smooth muscle, pooling of glycosaminoglycans within the media, and remodeling of fibrillar collagens – within the different types of TAADs.
Conclusions
Thoracic aortic aneurysms and dissections are responsible for significant morbidity and mortality across a wide range of ages. Due in large part to advances in genetics and medical imaging, the number of diagnosed TAADs has increased two-to-four fold over the past three decades [13,43] and there is a correspondingly greater need for a better understanding of this disease [3,9,16,106]. Many of the best reviews on TAADs have not considered the potential structural implications of GAGs/PGs (cf. [3,16,107,108]) despite the pooling of GAGs/PGs consistently being recognized as one of the four primary histological features of TAADs (e.g., [9,12,13]). Similarly, many of the best reviews on TGF-β in vascular health and disease (cf. [37,40,41,50]) have not emphasized the well documented effects of TGF-β in promoting GAG/PGs synthesis (cf. [57,66,68]). Given that the natural history of TAADs depends strongly on the mechanics and underlying mechanobiology [3,9,51,71], even to the point that past clinical treatment has focused on minimizing wall stress that results from hypertension or extreme physical exertion [108,109], and that “the powerful techniques of mechanical analysis have not been widely applied to study of the thoracic aorta” [110], it is suggested here that there is a pressing need for a rigorous analysis of the possible mechanical consequences of the singularly important histopathological characteristic of pooled GAGs/PGs in TAADs. Moreover, given significant and diverse evidence that increased availability of active TGF-β is both a hallmark of many different types of TAADs and a promoter of GAG/PGs synthesis, there is also a pressing need for increased attention to this possible downstream consequence of dysregulated TGF-β. Taken together, mechanical and biological research along these lines may help explain why the thoracic aortic wall becomes increasingly susceptible to the mechanical processes of dissection and rupture despite an otherwise expected pro-fibrotic and potentially protective response.
Acknowledgments
I have benefitted tremendously from thoughtful discussions with Professor Dianna Milewicz, University of Texas – Houston, regarding TAADs and Professor Gerard Ateshian, Columbia University, regarding the biomechanics of GAGs/PGs. I also thank Professor Gerald Meininger, University of Missouri, for inviting this review. This work was supported, in part, by a grant from the NIH (HL107768).
References
- 1.Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577–1589. doi: 10.1016/S0140-6736(05)66459-8. [DOI] [PubMed] [Google Scholar]
- 2.Socci L, Pennati G, Gastaldi D, Vena P. Modeling and mechanobiology of cerebral aneurysms. J Appl Biomat Biomech. 2008;6:63–71. [PubMed] [Google Scholar]
- 3.El-Hamamsy I, Yacoub MH. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nature Rev – Cardiol. 2009;6:771–786. doi: 10.1038/nrcardio.2009.191. [DOI] [PubMed] [Google Scholar]
- 4.Schlatmann TJM, Becker AE. Pathogenesis of dissecting aneurysm of aorta: Comparitive histopathologic study of significance of medial changes. Am J Cardiol. 1977;39:21–26. doi: 10.1016/s0002-9149(77)80005-2. [DOI] [PubMed] [Google Scholar]
- 5.Cattell MA, Hasleton PS, Anderson JC. Glycosaminoglycan content is increased in dissecting aneurysms of human thoracic aorta. Clin Chim Acta. 1994;226:29–46. doi: 10.1016/0009-8981(94)90100-7. [DOI] [PubMed] [Google Scholar]
- 6.Borges LF, Touat Z, Leclercq A, Al Haj Zen A, Joundeau G, Franc B, Philippe M, Meilhac O, Gutierrez PS, Michel JB. Tissue diffusion and retention of metalloproteinases in ascending aortic aneurysms and dissections. Hum Path. 2009;40:306–313. doi: 10.1016/j.humpath.2008.08.002. [DOI] [PubMed] [Google Scholar]
- 7.Nataatmadja M, West J, West M. Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation. 2006;114:I-371–377. doi: 10.1161/CIRCULATIONAHA.105.000927. [DOI] [PubMed] [Google Scholar]
- 8.Collins MJ, Dev V, Strauss BH, Fedak PWM, Butany J. Variation in the histopathological features of patients with ascending aortic aneurysms: a study of 111 surgically excised cases. J Clin Pathol. 2008;61:519–523. doi: 10.1136/jcp.2006.046250. [DOI] [PubMed] [Google Scholar]
- 9.Milewicz DM, Gou DC, Fadulu VT, Lafont AL, Papke CL, Inamoto S, Kwartler CS, Pannu H. Genetic basis of thoracic aortic aneurysms and dissections. Focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet. 2008;2008(9):283–302. doi: 10.1146/annurev.genom.8.080706.092303. [DOI] [PubMed] [Google Scholar]
- 10.Maleszewski JJ, Miller DV, Lu J, Dietz HC, Halushka MK. Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS) AM J Surg Path. 2009;33:194–201. doi: 10.1097/PAS.0b013e31817f3661. [DOI] [PubMed] [Google Scholar]
- 11.Jain D, Dietz HC, Oswald GL, Maleszewski JJ, Halushka MK. Causes and histopathology of ascending aortic disease in children and young adults. Cardiovasc Path. 2011;20:15–25. doi: 10.1016/j.carpath.2009.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Grond-Ginsbach C, Pjonteck R, Aksay SS, Hyhlik-Durr A, Bockler D, Gross-Weissmann M-L. Spontaneous arterial dissection: Phenotype and molecular pathogenesis. Cell Mol Life Sci. 2010;67:1799–1815. doi: 10.1007/s00018-010-0276-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Bode-Janisch S, Schmidt A, Gunther D, Stuhrmann M, Fieguth A. Aortic dissecting aneurysms – Histopathological findings. Forensic Sci Int. 2011;214:13–17. doi: 10.1016/j.forsciint.2011.07.006. [DOI] [PubMed] [Google Scholar]
- 14.Guo DC, Regalado ES, Minn C, Tran-Fadulu V, Coney J, Cao J, Wang M, Yu RK, Estrera AL, Safi HJ, Shete SS, Milewicz DM. Familial thoracic aneurysms and dissections: Identification of a novel locus for stable aneurysms with a low risk for progression to aortic dissection. Circ Cardiovasc Genet. 2011;4:36–42. doi: 10.1161/CIRCGENETICS.110.958066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Halushka MK. Single gene disorders of the aortic wall. Cardiovasc Path. 2011 doi: 10.1016/j.carpath.2011.09.004. (in press) [DOI] [PubMed] [Google Scholar]
- 16.Lindsay ME, Dietz HC. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature. 2011;473:308–316. doi: 10.1038/nature10145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ilopoulos DC, Kritharis EP, Giagini AT, Papadodima SA, Sokolis DP. Ascending thoracic aortic aneurysms associated with compositional remodeling and vessel stiffening but not weakening in age matched subjects. J Thorac Cardiovasc Surg. 2009;137:101–109. doi: 10.1016/j.jtcvs.2008.07.023. [DOI] [PubMed] [Google Scholar]
- 18.Dingemans RP, Teeling P, Lagendijk JH, Becker AE. Extracellular matrix of the human aortic media: An ultrastructural histochemical and immunohistochemical study of the adult aortic media. Anat Record. 2000;258:1–14. doi: 10.1002/(SICI)1097-0185(20000101)258:1<1::AID-AR1>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
- 19.Rhodin JAG. Architecture of the vessel wall. In: Berne RM, editor. Handbook of Physiology, Section 2. Vol. 2. American Physiological Society; MD: 1979. [Google Scholar]
- 20.Lindeman JHN, Ashcroft BA, Beenakker JWM, van Es M, Koekkoek NBR, Prins FA, Tielemans JF, Abdul-Hussien H, Bank RA, Oosterkamp TH. Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndrome. PNAS. 2010;107:862–865. doi: 10.1073/pnas.0910312107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Humphrey JD. Cardiovascular Solid Mechanics: Cells, Tissues, and Organs. Springer; NY: 2002. [Google Scholar]
- 22.Humphrey JD. Vascular adaptation and mechanical homeostasis at tissue, cellular, and sub-cellular levels. Cell Biochem Biophys. 2008;50:53–78. doi: 10.1007/s12013-007-9002-3. [DOI] [PubMed] [Google Scholar]
- 23.Wagenseil JE, Mecham RP. Vascular extracellular matrix and arterial mechanics. Physiol Rev. 2009;89:957–989. doi: 10.1152/physrev.00041.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Rodriguez-Feo JA, Sluijter JPG, Pasterkamp G. Modulation of collagen turnover in cardiovascular disease. Curr Pharmacol Design. 2005;11:2501–2514. doi: 10.2174/1381612054367544. [DOI] [PubMed] [Google Scholar]
- 25.Arribas SM, Hinek A, González MC. Elastic fibres and vascular structure in hypertension. Pharmacol Therapeu. 2006;111:771–791. doi: 10.1016/j.pharmthera.2005.12.003. [DOI] [PubMed] [Google Scholar]
- 26.Van Baardwijk C, Roach MR. Factors in the propagation of aortic dissections in canine thoracic aortas. J Biomech. 1987;20:67–73. doi: 10.1016/0021-9290(87)90268-5. [DOI] [PubMed] [Google Scholar]
- 27.Sommer G, Gasser TC, Regitnig P, Auer M, Holzapfel GA. Dissection properties of the human aortic media: An experimental study. J Biomech Engr. 2006;130:021007. doi: 10.1115/1.2898733. [DOI] [PubMed] [Google Scholar]
- 28.Khoynezhad A, Walot I, Kruse MJ, Rapae T, Donayre CE, White FA. Distribution of intimomedial tears in patients with type B aortic dissection. J Vasc Surg. 2010;52:562–568. doi: 10.1016/j.jvs.2010.04.036. [DOI] [PubMed] [Google Scholar]
- 29.Wilson SK, Hutchins GM. Aortic dissecting aneurysms: Causative factors in 204 subjects. Arch Pathol Lab Med. 1982;106:175–180. [PubMed] [Google Scholar]
- 30.Tse KM, Chiu P, Lee HP, Ho P. Investigation of hemodynamics in the development of dissecting aneurysm within patient-specific dissecting aneurismal aortas using computational fluid dynamics (CFD) simulations. J Biomech. 2011;44:827–836. doi: 10.1016/j.jbiomech.2010.12.014. [DOI] [PubMed] [Google Scholar]
- 31.Matt P, Huso DL, Habashi J, Holm T, Doyle J, Schoenhoff F, Liu G, Black J, van Eyk JE, Deitz HC. Murine model of surgically induced acute aortic dissection type A. J Thorac Cardiovasc Surg. 2010;139:1041–1047. doi: 10.1016/j.jtcvs.2009.08.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Chung AWY, Yeung KA, Sandor GGS, Judge DP, Dietz HC, van Breeman C. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ Res. 2007;101:512–522. doi: 10.1161/CIRCRESAHA.107.157776. [DOI] [PubMed] [Google Scholar]
- 33.Ferruzzi J, Collins MJ, Yeh AT, Humphrey JD. Mechanical assessment of elastin integrity in fibrillin-1 deficient carotid arteries: Implications for Marfan syndrome. Cardiovasc Res. 2011;92:287–295. doi: 10.1093/cvr195. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Wilson JF, Baek S, Humphrey JD. Importance of initial aortic properties on the evolving regional anisotropy, stiffness and wall thickness of human abdominal aortic aneurysms. J R Soc Interface. 2012 doi: 10.1098/rsif.2012.0097. (in press) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Dietz HC, Loeys B, Carta L, Ramirez F. Recent progress towards a molecular understanding of Marfan syndrome. Am J Med Genet C Semin Med Genet. 2005;139:4–9. doi: 10.1002/ajmg.c.30068. [DOI] [PubMed] [Google Scholar]
- 36.Chaudhry SS, Cain SA, Morgan A, Dallas SL, Shuttleworth A, Kielty CM. Fibrillin-1 regulates the bioavailability of TGF-β1. J Cell Biol. 2007;176:355–367. doi: 10.1083/jcb.200608167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.ten Dijke P, Arthur HM. Extracellular control of TGFbeta signaling in vascular development and disease. Nat Rev Molc Cell Biol. 2007;8:857–869. doi: 10.1038/nrm2262. [DOI] [PubMed] [Google Scholar]
- 38.Inamoto S, Kwartler CS, Lafont AL, Liang YY, Fadulu VT, Duriaswamy S, Willing M, Estrera A, Safi H, Hannibal MC, Carey J, Wiktorowicz J, Tan FK, Feng XH, Pannu H, Milewicz DM. TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. Cardiovasc Res. 2010;88:520–529. doi: 10.1093/cvr/cvq230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Renard M, Callewaert B, Baetens M, Campens L, MacDermot K, Fryns JP, Bonduelle M, Dietz HC, Gaspar IM, Cavaco D, Stattin EL, Schrander-Stumpel C, Coucke P, Loeys B, de Paepe A, de Backer J. Novel MYH11 and ACTA2 mutations reveal a role of enhanced TGF-beta signaling in FTAAD. Int J Cardiol. 2011 doi: 10.1016/j.ijcard.2011.08.079. (in press) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ghosh J, Murphy MO, Turner N, Khwaja N, Halka A, Kielty CM, Walker MG. The role of transforming growth factor – beta 1 in the vascular system. Cardiovasc Path. 2005;14:28–36. doi: 10.1016/j.carpath.2004.11.005. [DOI] [PubMed] [Google Scholar]
- 41.Ruiz-Ortega M, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. TGF-beta signaling in vascular fibrosis. Cardiovasc Res. 2007;74:196–206. doi: 10.1016/j.cardiores.2007.02.008. [DOI] [PubMed] [Google Scholar]
- 42.Wang X, LeMaire SA, Chen L, Shen YH, Gan Y, Bartsch H, Carter SA, Utama B, Ou H, Coselli JS, Wang XL. Increased collagen deposition and elevated expression of connective tissue growth factor in human thoracic aortic dissection. Circulation. 2006;I:200–205. doi: 10.1161/CIRCULATIONAHA.105.000240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Theruvath TP, Jones JA, Ikonomidis JS. Matrix metalloproteinases and descending aortic aneurysms: Parity, disparity, and switch. J Card Surg. 2011;27:81–90. doi: 10.1111/j.1540-8191.2011.01315.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Dai J, Losy F, Guinault AM, Pages C, Anegon I, Desgranges P, Becquemin JP, Allaire E. Overexpression of transforming growth factor – beta 1 stabilizes already formed aortic aneurysms: A first approach to induction of functional healing by endovascular gene therapy. Circulation. 2005;112:1008–1015. doi: 10.1161/CIRCULATIONAHA.104.523357. [DOI] [PubMed] [Google Scholar]
- 45.Frutkin AD, Otsuka G, Otero-Stempien A, Sesti C, Du L, Jaffe M, Dichek HL, Pennington CJ, Edwards DR, Nieves-Cintron M, Minter D, Preusch M, Hu JH, Marie JC, Dichek DA. TGF-beta1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilatation in apolipoprotein E-null mice. Arterioscl Thromb Vasc Biol. 2009;29:1251–1257. doi: 10.1161/ATVBAHA.109.186593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT, Raaz U, Schoelmerich AM, Ralesdana A, Leeper NJ, McConnell MV, Dalman RP, Spin JM, Tsao PS. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest. 2012;122:497–506. doi: 10.1172/JCI61598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Milewicz DM. MicroRNAs, fibrotic remodeling, and aortic aneurysms. J Clin Invest. 2012;122:490–493. doi: 10.1172/JCI62204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Schmierer B, Hill CS. TGFβ – Smad signal transduction: molecular specificity and functional flexibility. Nature Reviews Molc Cell Biol. 2007;8:970–980. doi: 10.1038/nrm2297. [DOI] [PubMed] [Google Scholar]
- 49.Holm TM, Habashi JP, Doyle JJ, Bedja D, Chen YC, van Erp C, Lindsay ME, Kim D, Schoenhoff F, Cohn RD, Loeys B, Thomas CJ, Patmaik S, Marugan JJ, Judge DP, Dietz HC. Noncanonical TGF-beta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science. 2011;332:358–361. doi: 10.1126/science.1192149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Jones JA, Spinale FG, Ikonomidis JS. Transforming growth factor signaling in thoracic aortic aneurysm development: A paradox in pathogenesis. J Vasc Res. 2009;46:119–137. doi: 10.1159/000151766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Ruddy JM, Jones JA, Spinale FG, Ilonomidis JS. Regional heterogeneity within the aorta: Relevance to aneurysm disease. J Thorac Cardiovasc Surg. 2008;136:1123–1130. doi: 10.1016/j.jtcvs.2008.06.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Majesky MW, Dong XR, Hoglund VJ. Parsing aortic aneurysms: More surprises. Circ Res. 2011;108:528–530. doi: 10.1161/CIRCRESAHA.111.240861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Thieszen SL, Dalton M, Gadson PF, Patterson E, Rosenquist TH. Embryonic lineage of vascular smooth muscle cells determines responses to collagen matrices and integrin receptor expression. Exp Cell Res. 1996;227:135–145. doi: 10.1006/excr.1996.0258. [DOI] [PubMed] [Google Scholar]
- 54.Gadson PF, Dalton ML, Patterson E, Svoboda DD, Hutchinson L, Schram D, Rosenquist TH. Differential response of mesoderm- and neural crest-derived smooth muscle to TGF-beta 1: Regulation of c-myb and alpha 1 (I) procollagen genes. Exp Cell Res. 1997;230:169–180. doi: 10.1006/excr.1996.3398. [DOI] [PubMed] [Google Scholar]
- 55.Merk DR, Chin JT, Dake BA, Maegdefessel L, Miller MO, Kimura N, Tsao RO, Iosef C, Berry GJ, Mohr FW, Spin JM, Alvira CM, Robbins RC, Fischbein MP. miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res. 2012;110:312–324. doi: 10.1161/CIRCRESAHA.111.253740. [DOI] [PubMed] [Google Scholar]
- 56.Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell. Garland Science; New York: 2002. [Google Scholar]
- 57.Wight TN. Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front Biosci. 2008:4933–4937. doi: 10.2741/3052. [DOI] [PubMed] [Google Scholar]
- 58.Gupta V, Werdenberg JA, Lawrence BD, Mendez JS, Stephens EH, Grande-Allen KJ. Reversible secretion of glycosaminoglycans and proteoglycans by cyclically stretched valvular cells in 3D culture. Annl Biomed Engr. 2008;36:1092–1103. doi: 10.1007/s10439-008-9501-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Zhang G, Chen S, Goldoni S, Calder BW, Simpson HC, Owens RT, McQuillan DJ, Young MF, Iozzo RV, Birk DE. Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem. 2009;284:8888–8897. doi: 10.1074/jbc.M806590200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Baker AB. Role of proteoglycans in vascular mechanotransduction. In: Kamkin A, Kiseleva I, editors. Mechanosensitivity and Mechanotransduction. Springer; Heidelberg: 2011. [Google Scholar]
- 61.Turley EA. Extracellular matrix remodeling: Multiple paradigms in vascular diseases. Circ Res. 2001;88:2–4. doi: 10.1161/01.res.88.1.2. [DOI] [PubMed] [Google Scholar]
- 62.Heegaard AM, Corsi A, Danielsen CC, Nielsen KL, Jorgensen HL, Riminucci M, Young MF, Bianco P. Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation 2011. 2007;115:2731–2738. doi: 10.1161/CIRCULATIONAHA.106.653980. [DOI] [PubMed] [Google Scholar]
- 63.Dobrin PB, Baker WH, Gley WC. Elastolytic and collagenolytic studies of arteries. Experimentia. 1984;41:1040–1042. doi: 10.1001/archsurg.1984.01390160041009. [DOI] [PubMed] [Google Scholar]
- 64.Powell JT, Lanne T. Through thick and thin collagen fibrils, stress, and aortic rupture: Another piece of the jigsaw. Circulation. 2007;115:2687–2688. doi: 10.1161/CIRCULATIONAHA.107.709139. [DOI] [PubMed] [Google Scholar]
- 65.Reynertson RH, Parmley RT, Roden L, Oparil S. Proteoglycans and hypertension: I. A biochemical and ultrastructural study of aorta glycosaminoglycans in spontaneously hypertensive rats. Coll Relat Res. 1986;6:77–101. doi: 10.1016/s0174-173x(86)80033-4. [DOI] [PubMed] [Google Scholar]
- 66.Rasmussen LM, Wolf YG, Ruoslahti E. Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity. Am J Path. 1995;147:1041–1048. [PMC free article] [PubMed] [Google Scholar]
- 67.Aytekin M, Comhair SAA, de la Motte C, Bandyopadhyay SK, Farver CF, Hascall VC, Erzurum SC, Dweik RA. High levels of hyaluronan in idiopathic pulmonary arterial hypertension. Am J Physiol. 2008;295:L789–799. doi: 10.1152/ajplung.90306.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Yang SNY, Burch ML, Tannock LR, Evanko S, Osman N, Little PJ. Transforming growth factor-beta regulation of proteoglycan synthesis in vascular smooth muscle: Contribution to lipid binding and accelerated atherosclerosis in diabetes. J Diabetes. 2010;2:233–242. doi: 10.1111/j.1753-0407.2010.00089.x. [DOI] [PubMed] [Google Scholar]
- 69.Engle J, Safi HJ, Abbassi O, Iliopoulos DC, Dorsay D, Cartwright J, Weilbaecher D. Mucopolysaccharidosis presenting as pediatric multiple aortic aneurysm: first reported case. J Vasc Surg. 1997;26:704–710. doi: 10.1016/s0741-5214(97)70074-0. [DOI] [PubMed] [Google Scholar]
- 70.Ma Z, Tittiger M, Knutsen RH, Kovacs A, Schaller L, Mecham RP, Ponder KP. Upregulation of elastase proteins in aortic dilatation in mucopolysaccharidosis I mice. Molc Genet Metabol. 2008;94:298–304. doi: 10.1016/j.ymgme.2008.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Tang PCY, Coady MA, Lovoulos C, Dardik A, Aslan M, Elefteriades JA, Tellides G. Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms. Circulation. 2005;112:1098–1105. doi: 10.1161/CIRCULATIONAHA.104.511717. [DOI] [PubMed] [Google Scholar]
- 72.Sluijter JPG, de Kleijn DPV, Pasterkamp G. Vascular remodeling and protease inhibition – bench to bedside. Cardiovas Res. 2006;69:595–603. doi: 10.1016/j.cardiores.2005.11.026. [DOI] [PubMed] [Google Scholar]
- 73.Newby AC. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substances. Cardiovas Res. 2006;69:614–624. doi: 10.1016/j.cardiores.2005.08.002. [DOI] [PubMed] [Google Scholar]
- 74.Schonherr E, Jarvelainen HT, Sandell LJ, Wight TN. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem. 1991;266:17640–17647. [PubMed] [Google Scholar]
- 75.Schmidt A, Lorkowski S, Seidler D, Breithardt G, Buddecke E. TGF-beta 1 generates specific multicomponent extracellular matrix in human coronary SMC. Eur J Clin Invest. 2006;36:473–482. doi: 10.1111/j.1365-2362.2006.01658.x. [DOI] [PubMed] [Google Scholar]
- 76.Lee A, Dillmann WH, McCulloch AD, Villarreal FJ. Angiotensin II stimulates the autocrine production of transforming growth factor – beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol. 1995;27:2347–2357. doi: 10.1016/s0022-2828(95)91983-x. [DOI] [PubMed] [Google Scholar]
- 77.Guo N, Li X, Mann MM, Funderburgh ML, Du Y, Funderburgh JL. Hyaluronan synthesis mediates the fibrotic response of keratocytes to transforming growth factor beta. J Biol Chem. 2010;285:32012–32019. doi: 10.1074/jbc.M110.127183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Susarla BTS, Laing ED, Yu P, Katagiri Y, Geller HM, Symes AJ. Smad proteins differentially regulate transforming growth factor-beta-mediated induction of chondroitin sulfate proteoglycans. J Neurochem. 2011;119:868–878. doi: 10.1111/j.1471-4159.2011.07470.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Matalon R, Dorfman A. The accumulation of hyaluronic acid in cultured fibroblasts of the Marfan syndrome. Biochem Biophys Res Comm. 1968;32:150–154. doi: 10.1016/0006-291x(68)90361-6. [DOI] [PubMed] [Google Scholar]
- 80.Dzau VJ. Tissue angiotensin and pathology of vascular disease: A unifying hypothesis. Hypertension. 2001;37:1047–1052. doi: 10.1161/01.hyp.37.4.1047. [DOI] [PubMed] [Google Scholar]
- 81.Huang F, Thompson JC, Wilson PG, Aung HH, Rutledge JC, Tannock LR. Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development. J Lipid Res. 2008;49:521–530. doi: 10.1194/jlr.M700329-JLR200. [DOI] [PubMed] [Google Scholar]
- 82.Nagy N, Melchior-Becker A, Fischer JW. Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis. Basic Res Cardiol. 2010;105:29–38. doi: 10.1007/s00395-009-0051-1. [DOI] [PubMed] [Google Scholar]
- 83.Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:117–121. doi: 10.1126/science.1124287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Sobolewski K, Wolanska M, Bankowski E, Gacko M, Glowinski S. Collagen, elastin, and glycosaminoglycans in aortic aneurysms. Acta Biochim Polon. 1995;42:301–308. [PubMed] [Google Scholar]
- 85.Tamarina NA, Grassi MA, Johnson DA, Pearce WH. Proteoglycan gene expression is decreased in abdominal aortic aneurysms. J Surg Res. 1998;74:76–80. doi: 10.1006/jsre.1997.5201. [DOI] [PubMed] [Google Scholar]
- 86.Theocharis AD, Karamanos NK. Decreased biglycan expression and differential decorin localization in human abdominal aortic aneurysms. Atherosclerosis. 2002;165:221–230. doi: 10.1016/s0021-9150(02)00231-9. [DOI] [PubMed] [Google Scholar]
- 87.Porterfild SP, Calhoon TB, Weiss HS. Changes in connective tissue colloidal charge density with atherosclerosis and age. Am J Physiol. 1968;215:324–329. doi: 10.1152/ajplegacy.1968.215.2.324. [DOI] [PubMed] [Google Scholar]
- 88.Azeloglu EU, Albro MB, Thimmappa VA, Ateshian GA, Costa KD. Heterogeneous transmural proteoglycan distribution provides a mechanism for regulating residual stresses in the aorta. Am J Physiol. 2008;294:H1197–H1205. doi: 10.1152/ajpheart.01027.2007. [DOI] [PubMed] [Google Scholar]
- 89.Bian L, Angione SL, Ng KW, Lima EG, Williams DY, Mao DQ, Ateshian GA, Hung CT. Influence of decreasing nutrient path length on the development of engineered cartilage. Osteoarth Cartil. 2009;17:677–685. doi: 10.1016/j.joca.2008.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Tinoco I, Sauer K, Wang JC, Puglisi JD. Physical Chemistry, Principles and Applications in Biological Sciences. Prentice-Hall; NJ: 2002. [Google Scholar]
- 91.Maroudas A. Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature. 1976;260:808–809. doi: 10.1038/260808a0. [DOI] [PubMed] [Google Scholar]
- 92.Chahine NO, Chen FH, Hung CT, Ateshian GA. Direct measurement of osmotic pressure of glycosaminoglycans solutions by membrane osmometry at room temperature. Biophys J. 2005;89:1543–1550. doi: 10.1529/biophysj.104.057315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhia J, Wight TN. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys. 2001;394:29–38. doi: 10.1006/abbi.2001.2507. [DOI] [PubMed] [Google Scholar]
- 94.Hosoda Y, Iri H. A histological and histochemical study on successive changes of the lathyritic rat aorta. Acta Path. 1966;16:239–252. doi: 10.1111/j.1440-1827.1966.tb01957.x. [DOI] [PubMed] [Google Scholar]
- 95.Lesauskaite V, Tanganelli P, Sassi C, Neri E, DiCiolla F, Ivanoviene L, Epistolato MC, Lalinga AV, Alessandrini C, Spina D. Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. Human Pathol. 2001;32:1003–1011. doi: 10.1053/hupa.2001.27107. [DOI] [PubMed] [Google Scholar]
- 96.Nakashima Y, Sueishi K. Alteration of elastic architecture in the lathyritic rat aorta implies the pathogenesis of aortic dissecting aneurysm. Am J Path. 1992;140:959–969. [PMC free article] [PubMed] [Google Scholar]
- 97.Bunton TE, Biery J, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res. 2001;88:37–43. doi: 10.1161/01.res.88.1.37. [DOI] [PubMed] [Google Scholar]
- 98.Hornebeck W, Emonard H. The cell-elastin-elastase(s) interacting triade directs elastolysis. Front Biosci. 2011;16:707–722. doi: 10.2741/3714. [DOI] [PubMed] [Google Scholar]
- 99.Jondeau G, Boutouyrie P, Lacolley P, Laloux B, Dubourg O, Bourdarias J-P, Laurent S. Central pulse pressure is a major determinant of ascending aorta dilatation in Marfan syndrome. Circulation. 1999;99:2677–2681. doi: 10.1161/01.cir.99.20.2677. [DOI] [PubMed] [Google Scholar]
- 100.O’Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension. 2005;45:652–658. doi: 10.1161/01.HYP.0000153793.84859.b8. [DOI] [PubMed] [Google Scholar]
- 101.Pasta S, Phillippi JA, Gleason TG, Vorp DA. Effect of aneurysm on the mechanical dissection properties of the human ascending thoracic aorta. J Thorac Cardiovasc Surg. 2012;143:460–467. doi: 10.1016/j.jtcvs.2011.07.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Humphrey JD, Taylor CA. Intracranial and abdominal aortic aneurysms: Similarities, differences, and need for a new class of computational models. Annu Rev Biomed Engr. 2008;10:221–246. doi: 10.1146/annurev.bioeng.10.061807.160439. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Beller CJ, Labrosse MR, Thubrikar MJ, Robicsek F. Finite element modeling of the thoracic aorta: including aortic root motion to evaluate risk of aortic dissection. J Med Engr Tech. 2008;32:167–170. doi: 10.1080/03091900600687672. [DOI] [PubMed] [Google Scholar]
- 104.Nathan DP, Xu C, Gorman JH, Fairman RM, Bavaria JE, Gorman RC, Chandran KB, Jackson BM. Pathogenesis of acute aortic dissection: A finite element stress analysis. Ann Thorac Surg. 2011;91:458–464. doi: 10.1016/j.athoracsur.2010.10.042. [DOI] [PubMed] [Google Scholar]
- 105.Khanafer K, Berguer R. Fluid-structure interaction analysis of turbulent pulsatile flow within a layered aortic wall as related to aortic dissection. J Biomech. 2009;42:2642–2648. doi: 10.1016/j.jbiomech.2009.08.010. [DOI] [PubMed] [Google Scholar]
- 106.Kroner BL, Tolunay HE, Basson CT, Pyeritz RE, Holmes KW, Maslen CL, Milewicz DM, LeMaire SA, Hendershot T, Desvigne-Nickens P, Devereux RB, Dietz HC, Song HK, Ringer D, Mitchell M, Weinsaft JW, Ravekes W, Menashe V, Eagle KA. The national registry of genetically triggered thoracic aortic aneurysms and cardiovascular conditions (GenTAC): Results from phase I and scientific opportunities in phase II. Am Heart J. 2011;162:627–632. doi: 10.1016/j.ahj.2011.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Barbour JR, Spinale FG, Ikonomidis JS. Proteinase systems and thoracic aortic aneurysm progression. J Surg Res. 2007;139:292–307. doi: 10.1016/j.jss.2006.09.020. [DOI] [PubMed] [Google Scholar]
- 108.Elefteriades JA, Farkas EA. Thoracic aortic aneurysm: Clinically pertinent controversies and uncertainties. J Am Coll Cardiol. 2010;55:841–857. doi: 10.1016/j.jacc.2009.08.084. [DOI] [PubMed] [Google Scholar]
- 109.Mayerick C, Carre F, Elefteriades J. Aortic dissection and sport: physiologic and clinical understanding provide an opportunity to save young lives. J Cardiovasc Surg (Torino) 2010;51:669–681. [PubMed] [Google Scholar]
- 110.Koullias G, Modak R, Tranquilli M, Korkolis DP, Barash P, Elefteriades JA. Mechanical deterioration underlies malignant behavior of aneurysmal human ascending aorta. J Thorac Cardiovasc Surg. 2005;130:677–683. doi: 10.1016/j.jtcvs.2005.02.052. [DOI] [PubMed] [Google Scholar]


